|
|
||||||||



* Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892
Aspergillus fumigatus, a common mold, rarely infects humans, except during prolonged neutropenia or in cases of chronic granulomatous disease (CGD), a primary immunodeficiency caused by mutations in the NADPH oxidase that normally produces fungicidal reactive oxygen species. Filamentous hyphae of Aspergillus are killed by normal, but not CGD polymorphonuclear leukocytes (PMN); however, the few studies on PMN-mediated host defenses against infectious conidia (spores) of this organism have yielded conflicting results, some showing that PMN do not inhibit conidial growth, with others showing that they do, most likely using reactive oxygen species. Given that CGD patients are exposed daily to hundreds of viable A. fumigatus conidia, yet considerable numbers of them survive years without infection, we reasoned that PMN use ROS-independent mechanisms to combat Aspergillus. We show that human PMN from both normal controls and CGD patients are equipotent at arresting the growth of Aspergillus conidia in vitro, indicating the presence of a reactive oxygen species-independent factor(s). Cell-free supernatants of degranulated normal and CGD neutrophils both suppressed fungal growth and were found to be rich in lactoferrin, an abundant PMN secondary granule protein. Purified iron-poor lactoferrin at concentrations occurring in PMN supernatants (and reported in human mucosal secretions in vivo) decreased fungal growth, whereas saturation of lactoferrin or PMN supernatants with iron, or testing in the presence of excess iron in the form of ferritin, completely abolished activity against conidia. These results demonstrate that PMN lactoferrin sequestration of iron is important for host defense against Aspergillus.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by the Intramural Research Program of the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health Clinical Center.
2 K.A.Z. and J.A.S. contributed equally to this study.
3 Address correspondence and reprint requests to Dr. John I. Gallin, 10 Center Drive, RM 6-2551, MSC 1504, Bethesda, MD 20892-1504; E-mail address: jgallin{at}cc.nih.gov or Dr. Kyung J. Kwon-Chung, 10 Center Drive, RM 11C304, Bethesda, MD 20892; E-mail address: june_kwon-chung{at}nih.gov
4 Abbreviations used in this paper: CGD, chronic granulomatous disease; CMFDA, carboxymethylfluoroscene diacetate; LF, lactoferrin; PMN, polymorphonuclear leukocyte; XTT, 2,3-bis-(2-methoxy-4-nitro-5-sulphenyl)-(2H)-tetrazolium-5-carboxanilide.
This article has been cited by other articles:
![]() |
S. J. Park and B. Mehrad Innate Immunity to Aspergillus Species Clin. Microbiol. Rev., October 1, 2009; 22(4): 535 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D'Angelo, A. De Luca, T. Zelante, P. Bonifazi, S. Moretti, G. Giovannini, R. G. Iannitti, S. Zagarella, S. Bozza, S. Campo, et al. Exogenous Pentraxin 3 Restores Antifungal Resistance and Restrains Inflammation in Murine Chronic Granulomatous Disease J. Immunol., October 1, 2009; 183(7): 4609 - 4618. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bianchi, A. Hakkim, V. Brinkmann, U. Siler, R. A. Seger, A. Zychlinsky, and J. Reichenbach Restoration of NET formation by gene therapy in CGD controls aspergillosis Blood, September 24, 2009; 114(13): 2619 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Standish and J. N. Weiser Human Neutrophils Kill Streptococcus pneumoniae via Serine Proteases J. Immunol., August 15, 2009; 183(4): 2602 - 2609. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. T. Dagenais and N. P. Keller Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis Clin. Microbiol. Rev., July 1, 2009; 22(3): 447 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Zarember, A. R. Cruz, C.-Y. Huang, and J. I. Gallin Antifungal Activities of Natural and Synthetic Iron Chelators Alone and in Combination with Azole and Polyene Antibiotics against Aspergillus fumigatus Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2654 - 2656. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Singh, K. A. Zarember, D. B. Kuhns, and J. I. Gallin Impaired Priming and Activation of the Neutrophil NADPH Oxidase in Patients with IRAK4 or NEMO Deficiency J. Immunol., May 15, 2009; 182(10): 6410 - 6417. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Segal Aspergillosis N. Engl. J. Med., April 30, 2009; 360(18): 1870 - 1884. [Full Text] [PDF] |
||||
![]() |
J. L. Werner, A. E. Metz, D. Horn, T. R. Schoeb, M. M. Hewitt, L. M. Schwiebert, I. Faro-Trindade, G. D. Brown, and C. Steele Requisite Role for the Dectin-1 {beta}-Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus J. Immunol., April 15, 2009; 182(8): 4938 - 4946. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Fortwendel, K. K. Fuller, T. J. Stephens, W. C. Bacon, D. S. Askew, and J. C. Rhodes Aspergillus fumigatus RasA Regulates Asexual Development and Cell Wall Integrity Eukaryot. Cell, September 1, 2008; 7(9): 1530 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lessing, O. Kniemeyer, I. Wozniok, J. Loeffler, O. Kurzai, A. Haertl, and A. A. Brakhage The Aspergillus fumigatus Transcriptional Regulator AfYap1 Represents the Major Regulator for Defense against Reactive Oxygen Intermediates but Is Dispensable for Pathogenicity in an Intranasal Mouse Infection Model Eukaryot. Cell, December 1, 2007; 6(12): 2290 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Hohl and M. Feldmesser Aspergillus fumigatus: Principles of Pathogenesis and Host Defense Eukaryot. Cell, November 1, 2007; 6(11): 1953 - 1963. [Full Text] [PDF] |
||||
![]() |
J. A. Sugui, J. Pardo, Y. C. Chang, K. A. Zarember, G. Nardone, E. M. Galvez, A. Mullbacher, J. I. Gallin, M. M. Simon, and K. J. Kwon-Chung Gliotoxin Is a Virulence Factor of Aspergillus fumigatus: gliP Deletion Attenuates Virulence in Mice Immunosuppressed with Hydrocortisone Eukaryot. Cell, September 1, 2007; 6(9): 1562 - 1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Sugui, J. Pardo, Y. C. Chang, A. Mullbacher, K. A. Zarember, E. M. Galvez, L. Brinster, P. Zerfas, J. I. Gallin, M. M. Simon, et al. Role of laeA in the Regulation of alb1, gliP, Conidial Morphology, and Virulence in Aspergillus fumigatus Eukaryot. Cell, September 1, 2007; 6(9): 1552 - 1561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |